Stock exchanges & markets

Overview Watchlists

Roche receives FDA clearance for cobas eplex RP3 respiratory panel

(AWP Alliance News) - Roche received FDA 510(k) clearance for its cobas eplex respiratory pathogen panel 3. The test detects up to 19 viruses and bacteria, delivering results in under two hours. Labs can choose from up to five panel configurations tailored to local patient needs.

https://www.prnewswire.com/news-releases/roche-receives-fda-510k-cleara…

Disclaimer: This news brief was created using generative artificial intelligence. Roche Holding AG published the original content used to generate this news brief via PR Newswire on November 02, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now